1. Bardy GH, Lee KL, Mark DB, Poole JE, Packer DL, Boineau R, Domanski M, Troutman C, Anderson J, Johnson G, McNulty SE, Clapp-Channing N, Davidson-Ray LD, Fraulo ES, Fishbein DP, Luceri RM, Ip JH (2005) Sudden cardiac death in heart failure trial (SCD-HeFT) investigators. Amiodarone or an implantable cardioverter-defibrillator for congestive heart failure. N Engl J Med 352(3):225–237
2. Chun S (2002) Improved patient care in the US with home monitoring pacemakers (abstract). Europace 3(Suppl A):A71
3. Deharo JC, Djiane P (2006) Home monitoring: what can we expect from the future? Clin Res Cardiol 95(Suppl 3):III/36–III/39
4. Elsner CH, Sommer P, Piorkowski C, Taborsky M, Neuser H, Bytesnik J, Geller JC, Kottkamp H, Wismeth H, Hindricks G (2006) A prospective multicenter comparison trial of home monitoring against regular follow-up in Madit II patients: additional visits and cost impact. Comput Cardiol 33:241–244
5. Fauchier L, Sadoul N, Kouakam C, Briand F, Chauvin M, Babuty D, Clementy J (2005) Potential cost savings by telemedicine-assisted long-term care of implantable cardioverter defibrillator recipients. Pacing Clin Electrophysiol 28:S255–S259